DOCSLIB.ORG

Images You Should Know

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Images You Should Know 6/5/2020 A Rapid Review of Key Course Images You have seen most of these during the course. On the exam they will give you more clinical context, which will make image recognition easier. But… this is mostly a review! Blood Smears 1. What Are These Images? Both Are Same Organism 1. Morula of Ehrlichia Chaffeensis in a Monocyte 2. What Are These Images? (Both Are Same Organism) 2. Morula of Anaplasma in Neutrophils 3. What Is This Image? 3. Borrelia in Peripheral Smear 4. What Is This Gram Negative Rod in the Peripheral Blood of a Splenectomized Septic Patient Licked by a Dog? Wald, Images in Hematology, Am. J. Hematol. 83:879 Researchgate.net 4. Capnocytophaga canimorsus Wald, Images in Hematology, Am. J. Hematol. 83:879 Researchgate.net 5. What Are These Images in an HIV-Infected Patient in the US (CD4=20 cells/uL) with Septic Shock? All Are Same Organism 5. Histoplasma in Leukocytes (Peripheral Smear) 6. What Are These Images from a Skin Biopsy of a Recent Immigrant from Brazil with Fever and Hepatosplenomegaly? 6. Leishmania Note Difference Between Leishmania (kinetoplast and nucleus) and Histoplasma in Image 5 (nucleus only) Visceral Leishmania would be in bone marrow, liver, spleen while cutaneous or mucocutaneous would be in skin or mucous membranes. Leishmania would not be seen in blood smears, unlike histoplasma. 7. What Is This Image in a Patient Who Develops Renal Failure After a Prodrome of Diarrhea and Abdominal Pain? 7. Schistocytes, Helmet Cells, and Thrombocytopenia Hemolytic Uremic Syndrome (HUS) or Thrombotic Thrombocytopenic Purpura (TTP) Schistocytes No Platelets 8. What Is This Image in a Patient with a Non-Specific Febrile Illness? 8. Atypical Lymphocytes EBV and…Many Other Viral and Non Viral Organisms 9. What Two Different Organisms are Demonstrated in These Images from Travelers Who Returned from East Africa (left) and Brazil (right)? 9. Trypanosoma brucei rhodesiensis Trypanosoma brucei rhodesiensis Trypanosoma cruzi (Sleeping Sickness, e.g., East Africa) (Chagas Disease, e.g., Brazil) Peripheral Smear Peripheral Smear 10. What Is This Image in a Febrile Person Who Has Only Resided on the Eastern Seaboard of the US? 10. Babesia in Erythrocytes 11. What Is This Image in a Traveler Who Returned from a Trip That Included West Africa and Asia? 11. Band Form Plasmodium malariae (Asia and West Africa) or knowlesii (Asia) 12. What Is This Image in a Traveler Who Returned from Malarious Areas? 12. Gametocyte Falciparum Malaria 13. What Is This Image in a Traveler Who Returned from Africa? 13. Vivax Malaria Schizont Xrays 14. What Are These Serial Images in a Patient with Lymphoma and Resolving Neutropenia? 14. Halo (left) and Crescent (right) Signs Neutropenia (left) and Resolving Neutropenia (right) Probably Aspergillus The above is aspergillus which is different from… To the left is the reverse halo sign due to mucor or… Cryptogenic organizing pneumonia COP 15. What Is This Image in a COPD Patient with Hemoptysis? 15. Fungus Ball in Pre Existing Cavity Probable Aspergilloma 16. What is Cause of this Bulging, Non Pulsatile Chest Mass in Adult Male with 3 Months of Fever, Weight Loss, Dyspnea, and Cough? Caceres corner no 34 http://blog.myesr.org/caceres‐corner‐case‐no‐34/ 16. Empyema Extending Through the Parietal Pleura into Surrounding Tissues Many Causes: TB, Actinomyces, Staph, Molds Caceres corner no 34 http://blog.myesr.org/caceres‐corner‐case‐no‐34/ 17. What is the Cause of Fever and Chills in this Male Who Had a Sudden Neurologic Event One Week After a Radiofrequency Ablation for Recurrent Arrhythmias? 17. Left Atrial Esophageal Fistula Due to Radiofrequency Ablation Complications Include Air Embolus Causing Stroke and Bacteremia Due to Draining Oral Flora Desai et al, Journal of the American College of Cardiology Volume 71, Issue 11 Supplement, March 2018 18. Why Does This Patient with a Severe Sore Throat Have Pulmonary Embolic Lesions? 18. Lemierre’s Syndrome Usually Fusobacterium Bacteremia On the first image, note the clot in the jugular system (red arrow) (the blue arrow shows complete filling with dye or contralateral jugular Image on right shows sagital view of jugular system with clot 19. What Is This Image in an AIDS Patient? 19. Primary Effusion Cell Lymphoma in HIV 20. What Is This Image in a Previously Healthy Patient with Fever and Chills and Dysuria? Sireineni et al, https://abdominalkey.com/uroradiology/ 20. Eggshell Calcifications of the Bladder Chronic Schistosoma Hematobium with Hydroureter Sireineni et al, https://abdominalkey.com/uroradiology/ 21. What Is the Cause of 5 Days of Abdominal Pain Associated with Fever, Nausea, and Vomiting in this 70 Year Old Diabetic? Sireineni et al, https://abdominalkey.com/uroradiology/ 21. Emphysematous Cystitis Due to Gas Forming Organism, Usually E. coli or Klebsiella and Responds to Medical Therapy Sireineni et al, https://abdominalkey.com/uroradiology/ 22. What Is This Image in a Previously Healthy Patient with Fever and Chills? 22. Emphysematous Pyelonephritis Due to Gas Forming Bacteria 23. What Is This Image in a Patient with Fever and Dysuria and a Renal Biopsy Showing Lipid Laden Macrophages? 23. Xanthogranulomatous Pyelonephritis 24. What Is This Image in a Healthy Patient with Severe Diarrhea? 24. Pneumatosis Intestinalis Emergent Surgery Unnecessary If No Clinical Sepsis, i.e., Unexplained Hypotension, Hyperlactemia, Metabolic Acidosis, and If No Portal Gas, Bowel Obstruction, Signs of Peritonitis or Perforation 25. What Is This Image in a Neutropenic Patient with Abdominal Pain ? 25. Typhlitis in Neutropenic Patient 25. Note Differences Appendicitis vs Typhlitis Normal appendix Appendicitis with Appendicolith Contrast is seen filling a normal appearing An enlarged appendix (solid arrows) is seen appendix (arrows) demonstrating a thin wall with an appendicolith (dashed arrows) at the base Appendicitis Perforated appendicitis The appendix (solid arrows) is abnormally The appendix (solid arrows) is abnormally dilated dilated and demonstrates a thickened with a thickened enhancing wall. Small pockets of enhancing wall and no filling with contrast. extraluminal air (dashed arrows) indicate perforation. http://www.massgeneral.org/imaging/news/radrounds/january_2006/ 26. What Is This Image in an AIDS Patient (CD4=10 cells/uL) Who Just Started ART? 26. Mycobacterium Avium IRIS Syndrome in HIV/AIDS Could Also Be Other Mycobacteria, Fungi, Lymphoma 27. What Are These Images in a Patient with Resolving Neutropenia? Cornely et al. Clinical Liver Disease, Vol 6, No 2, August 2015 Fontanilla, https://radiopaedia.org/cases/hepatic-candidiasis-on-contrast-enhanced-ultrasound 27. Hepatosplenic Candidiasis in Resolving Neutropenia Cornely et al. Clinical Liver Disease, Vol 6, No 2, August 2015 Fontanilla, https://radiopaedia.org/cases/hepatic-candidiasis-on-contrast-enhanced-ultrasound 28. What Is This Image in a Healthy Patient with Fever and Acutely Aberrant Behavior? http://www.med.harvard.edu 28. Herpes simplex Encephalitis Temporal Lobe http://www.med.harvard.edu 29. What Are These Images in a Patient with Rheumatoid Arthritis and Progressive Confusion? 29. JC Encephalitis (Also known as PML-Progressive Multifocal Leukoencephalopathy) 30. What Is This Image in a Recent Stem Cell Transplant Recipient? 30. Posterior Reversible Encephalopathy Syndrome (PRES) 31. What Is the Cause of 3 Week Decline in Mental Function in An Afebrile Patient With No Other Medical Issues and Hyperintensity of the Cortex, Pulvinar and Dorsomedial Thalamic Nuclei, and Basal Ganglia? 31. Creutzfeldt–Jakob Disease The location “Pulvinar” Should Be a Clue CSF Will Show 14-3-3 and Tau Proteins A. Normal FLAIR image for comparison B. Grade 2 hyperintensity of pulvinar C. Grade 3 hyperintensity of pulvinar D. Grade 4 hyperintensity of pulvinar The pulvinar sign refers to bilateral FLAIR hyperintensities involving the pulvinar thalamic nuclei, which is classically described in variant Creutzfeldt‐Jakob disease Collie, American Journal of Neuroradiology September 2003, 24 (8) 1560‐1569; 66 32. What Is This Image in a Healthy Patient with Fever and Facial Pain? 32. Ethmoidal Sinusitis 33. What Is This Image of Unilateral Disease of a Previously Healthy Patient with Fever but No Papilledema or Dysconjugate Gaze? R Itzaak Brook, http://sinusitisunderstood.blogspot.com/p/complications-and-referal.html 31. Orbital Cellulitis/Abscess Due to Ethmoidal Sinusitis Proptosis, Chemosis, Limitation of Extraocular Movement, Visual Loss R Itzaak Brook, http://sinusitisunderstood.blogspot.com/p/complications-and-referal.html 34. What Is This Image of Unilateral Disease in a Previously Healthy Patient with Fever, Ophthalmoplegia, Retinal Hemorrhages, Disc Edema, Vision Loss? Cooper, https://neuro-ophthalmology.Standford.edu. 34. Cavernous Sinus Thrombosis Associated with Sphenoid or Ethmoidal Sinusitis, Facial or Dental Infections Proptosis, Chemosis, Eyelid Edema, Cranial Nerve Palsies, Vision Loss Coronal T1 Image with Enlargement and Enhancement Of Sinus Due To Thrombosis Cooper, https://neuro-ophthalmology.Standford.edu. 35. What Sinus is Infected and What Complication Should be Sought? Interactive CT Sinus Anatomy: http://uwmsk.org/sinusanatomy2/SphenoidAbnormal.html 35. Sphenoid Sinusitis Associated with Cavernous Sinus Thrombosis Cavernous Sinus Thrombosis Sphenoid Sphenoid Sinusitis Sinusitis Cavernous Sinus Thrombosis Interactive CT Sinus Anatomy: http://uwmsk.org/sinusanatomy2/SphenoidAbnormal.html 36. What Is This Image in a Patient with a Severe Sore Throat
Recommended publications
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T

    WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
  • (12) United States Patent (10) Patent No.: US 9,018,158 B2 Onsoyen Et Al

    (12) United States Patent (10) Patent No.: US 9,018,158 B2 Onsoyen Et Al

    US0090181.58B2 (12) United States Patent (10) Patent No.: US 9,018,158 B2 Onsoyen et al. (45) Date of Patent: Apr. 28, 2015 (54) ALGINATE OLIGOMERS FOR USE IN 7,208,141 B2 * 4/2007 Montgomery .................. 424/45 OVERCOMING MULTIDRUG RESISTANCE 22:49 R: R388 al al W . aSOC ea. N BACTERA 7,671,102 B2 3/2010 Gaserod et al. 7,674,837 B2 3, 2010 G d et al. (75) Inventors: Edvar Onsoyen, Sandvika (NO); Rolf 7,758,856 B2 T/2010 it. Myrvold, Sandvika (NO); Arne Dessen, 7,776,839 B2 8/2010 Del Buono et al. Sandvika (NO); David Thomas, Cardiff 2006.8 R 38 8. Melist al. (GB); Timothy Rutland Walsh, Cardiff 2003/0022863 A1 1/2003 Stahlang et al. (GB) 2003/0224070 Al 12/2003 Sweazy et al. 2004/OO73964 A1 4/2004 Ellington et al. (73) Assignee: Algipharma AS, Sandvika (NO) 2004/0224922 A1 1 1/2004 King 2010.0068290 A1 3/2010 Ziegler et al. (*) Notice: Subject to any disclaimer, the term of this 2010/0305062 A1* 12/2010 Onsoyen et al. ................ 514/54 patent is extended or adjusted under 35 U.S.C. 154(b) by 184 days. FOREIGN PATENT DOCUMENTS DE 268865 A1 1, 1987 (21) Appl. No.: 13/376,164 EP O324720 A1 T, 1989 EP O 506,326 A2 9, 1992 (22) PCT Filed: Jun. 3, 2010 EP O590746 A1 4f1994 EP 1234584 A1 8, 2002 (86). PCT No.: PCT/GB2O1 O/OO1097 EP 1714660 A1 10, 2006 EP 1745705 A1 1, 2007 S371 (c)(1), FR T576 M 3/1968 (2), (4) Date: Jan.
  • Klebsiella Ornithinolytica

    Klebsiella Ornithinolytica

    international Journal of Systematic Bacteriology (1 999), 49, 1695-1 700 Printed in Great Britain Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb. nov. Jenny 5. Carter,’l2 Francis J. B~wden,~Ivan Ba~tian,~Garry M. Myers,’ K. S. Sriprakash’ and David J. Kemp’ Author for correspondence : David J. Kemp. Tel : + 6 18 8922 84 12. Fax : + 6 18 8927 5 187 e-mail : [email protected] 1 Menzies School of Health By sequencing a total of 2089 bp of the 16s rRNA and phoE genes it was Research, Darwin, demonstratedthat Calymmatobacterium grandomatis (the causative Austra Iia organism of donovanosis) shows a high level of identity with Klebsiella * Centre for Indigenous species pathogenic to humans (Klebsiellapneumoniae, Klebsiella Natural and Cultural Resource Management, rhinoscleromatis). It is proposed that C. grandomatis should be reclassified as Faculty of Aboriginal and Klebsiella granulomatis comb. nov. An emended description of the genus Torres Strait Islander Klebsiella is given. Studies, Northern Territory University, Darwin, Australia 3 Institute of Medical and Keywords : Calymmatobacteriurn, Klebsiella, sequence data, phylogenetic inferences Veterinary Science, Adelaide, Australia 4 AIDS/STD Unit, Royal Darwin Hospital, Darwin, Australia Calymmatobacterium granulomatis is the presumed ganism (Richens, 1991) have prevented further char- causative agent of donovanosis, an important cause of acterization of this relationship. genital ulceration that occurs in small endemic foci in all continents except Europe and Antarctica. The name Non-cultivable pathogenic eubacteria have been C. granulomatis was originally given to the pleo- identified by PCR using primers targeting conserved morphic bacterium cultured from donovanosis lesions genes (Fredricks & Relman, 1996).
  • Ohio Department of Health, Bureau of Infectious Diseases Disease Name Class A, Requires Immediate Phone Call to Local Health

    Ohio Department of Health, Bureau of Infectious Diseases Disease Name Class A, Requires Immediate Phone Call to Local Health

    Ohio Department of Health, Bureau of Infectious Diseases Reporting specifics for select diseases reportable by ELR Class A, requires immediate phone Susceptibilities specimen type Reportable test name (can change if Disease Name other specifics+ call to local health required* specifics~ state/federal case definition or department reporting requirements change) Culture independent diagnostic tests' (CIDT), like BioFire panel or BD MAX, E. histolytica Stain specimen = stool, bile results should be sent as E. histolytica DNA fluid, duodenal fluid, 260373001^DETECTED^SCT with E. histolytica Antigen Amebiasis (Entamoeba histolytica) No No tissue large intestine, disease/organism-specific DNA LOINC E. histolytica Antibody tissue small intestine codes OR a generic CIDT-LOINC code E. histolytica IgM with organism-specific DNA SNOMED E. histolytica IgG codes E. histolytica Total Antibody Ova and Parasite Anthrax Antibody Anthrax Antigen Anthrax EITB Acute Anthrax EITB Convalescent Anthrax Yes No Culture ELISA PCR Stain/microscopy Stain/spore ID Eastern Equine Encephalitis virus Antibody Eastern Equine Encephalitis virus IgG Antibody Eastern Equine Encephalitis virus IgM Arboviral neuroinvasive and non- Eastern Equine Encephalitis virus RNA neuroinvasive disease: Eastern equine California serogroup virus Antibody encephalitis virus disease; LaCrosse Equivocal results are accepted for all California serogroup virus IgG Antibody virus disease (other California arborviral diseases; California serogroup virus IgM Antibody specimen = blood, serum, serogroup
  • Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management

    Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management

    Am J Clin Dermatol 2011; 12 (3): 157-169 THERAPY IN PRACTICE 1175-0561/11/0003-0157/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management Douglas C. Wu,1 Wilson W. Chan,2 Andrei I. Metelitsa,1 Loretta Fiorillo1 and Andrew N. Lin1 1 Division of Dermatology, University of Alberta, Edmonton, Alberta, Canada 2 Department of Laboratory Medicine, Medical Microbiology, University of Alberta, Edmonton, Alberta, Canada Contents Abstract........................................................................................................... 158 1. Introduction . 158 1.1 Microbiology . 158 1.2 Pathogenesis . 158 1.3 Epidemiology: The Rise of Pseudomonas aeruginosa ............................................................. 158 2. Cutaneous Manifestations of P. aeruginosa Infection. 159 2.1 Primary P. aeruginosa Infections of the Skin . 159 2.1.1 Green Nail Syndrome. 159 2.1.2 Interdigital Infections . 159 2.1.3 Folliculitis . 159 2.1.4 Infections of the Ear . 160 2.2 P. aeruginosa Bacteremia . 160 2.2.1 Subcutaneous Nodules as a Sign of P. aeruginosa Bacteremia . 161 2.2.2 Ecthyma Gangrenosum . 161 2.2.3 Severe Skin and Soft Tissue Infection (SSTI): Gangrenous Cellulitis and Necrotizing Fasciitis. 161 2.2.4 Burn Wounds . 162 2.2.5 AIDS................................................................................................. 162 2.3 Other Cutaneous Manifestations . 162 3. Antimicrobial Therapy: General Principles . 163 3.1 The Development of Antibacterial Resistance . 163 3.2 Anti-Pseudomonal Agents . 163 3.3 Monotherapy versus Combination Therapy . 164 4. Antimicrobial Therapy: Specific Syndromes . 164 4.1 Primary P. aeruginosa Infections of the Skin . 164 4.1.1 Green Nail Syndrome. 164 4.1.2 Interdigital Infections . 165 4.1.3 Folliculitis .
  • The Old Testament Is Dying a Diagnosis and Recommended Treatment 1St Edition Download Free

    The Old Testament Is Dying a Diagnosis and Recommended Treatment 1St Edition Download Free

    THE OLD TESTAMENT IS DYING A DIAGNOSIS AND RECOMMENDED TREATMENT 1ST EDITION DOWNLOAD FREE Brent A Strawn | 9780801048883 | | | | | David T. Lamb Strawn offers a few other concrete suggestions about how to save the Old Testament, illustrating several of these by looking at the book of Deuteronomy as a model for second language acquisition. Retrieved 27 August The United States' Centers for Disease Control and Prevention CDC currently recommend that individuals who have been diagnosed and treated for gonorrhea avoid sexual contact with others until at least one week past the final day of treatment in order to prevent the spread of the bacterium. Brent Strawn reminds us of the Old Testament's important role in Christian faith and practice, criticizes current misunderstandings that contribute to its neglect, and offers ways to revitalize its use in the church. None, burning with urinationvaginal dischargedischarge from the penispelvic paintesticular pain [1]. Stunted language learners either: leave faith behind altogether; remain Christian, but look to other resources for how to live their lives; or balkanize in communities that prefer to speak something akin to baby talk — a pidgin-like form of the Old Testament and Bible as a whole — or, worse still, some sort of creole. Geoff, thanks for the reference. Log in. The guest easily identified the passage The Old Testament Is Dying A Diagnosis and Recommended Treatment 1st edition the New Testament, but the Old Testament passage was a swing, and a miss. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon.
  • Sexually Transmitted Diseases (Stds) 2016 Update Tirdad T

    Sexually Transmitted Diseases (Stds) 2016 Update Tirdad T

    Sexually Transmitted Diseases (STDs) 2016 Update Tirdad T. Zangeneh, DO, FACP Associate Professor of Clinical Medicine Division of Infectious Diseases University of Arizona – Banner Medical Center Disclosures • I have no financial relationships to disclose. • I will not discuss off-label use and/or investigational use in my presentation. • Slides provided by various sources including AETC, CDC, DHHS, and Dr. Sharon Adler. Arizona STDs 2014: 39,919 cases of STDs reported in Arizona: • Maricopa (64.4%) • Pima (16.8%) • Pinal (4.1%) • Yuma (2.6%) – 1.2% of investigated cases were co-infected with HIV – 22.8% of investigated cases were men who have sex with men (MSM) – 79.5% of all reported cases were young adults 15 – 29 years of age Arizona STDs • Pima County – 55 cases of syphilis in 2013 – 142 cases of syphilis in 2014 • As a result of the year to year increase, the syphilis rate in Pima County increased by 158% (14.2 cases per 100,000 population in 2014) Clinical Prevention Guidance The prevention and control of STDs are based on the following 5 major strategies: • Accurate risk assessment, education, and counseling on ways to avoid STDs through changes in sexual behaviors and use of recommended prevention services • Pre-exposure vaccination of persons at risk for vaccine- preventable STDs (Human Papillomavirus and Hepatitis B Virus • Identification of asymptomatically infected persons and persons with symptoms associated with STDs Clinical Prevention Guidance The prevention and control of STDs are based on the following 5 major strategies: • Effective diagnosis, treatment, counseling, and follow up of infected persons • Evaluation, treatment, and counseling of sex partners of persons who are infected with an STD The Five P’s approach to obtaining a sexual history 1.
  • Pediatric Cutaneous Bacterial Infections Dr

    Pediatric Cutaneous Bacterial Infections Dr

    PEDIATRIC CUTANEOUS BACTERIAL INFECTIONS DR. PEARL C. KWONG MD PHD BOARD CERTIFIED PEDIATRIC DERMATOLOGIST JACKSONVILLE, FLORIDA DISCLOSURE • No relevant relationships PRETEST QUESTIONS • In Staph scalded skin syndrome: • A. The staph bacteria can be isolated from the nares , conjunctiva or the perianal area • B. The patients always have associated multiple system involvement including GI hepatic MSK renal and CNS • C. common in adults and adolescents • D. can also be caused by Pseudomonas aeruginosa • E. None of the above PRETEST QUESTIONS • Scarlet fever • A. should be treated with penicillins • B. should be treated with sulfa drugs • C. can lead to toxic shock syndrome • D. can be associated with pharyngitis or circumoral pallor • E. Both A and D are correct PRETEST QUESTIONS • Strep can be treated with the following antibiotics • A. Penicillin • B. First generation cephalosporin • C. clindamycin • D. Septra • E. A B or C • F. A and D only PRETEST QUESTIONS • MRSA • A. is only acquired via hospital • B. can be acquired in the community • C. is more aggressive than OSSA • D. needs treatment with first generation cephalosporin • E. A and C • F. B and C CUTANEOUS BACTERIAL PATHOGENS • Staphylococcus aureus: OSSA and MRSA • Gp A Streptococcus GABHS • Pseudomonas aeruginosa CUTANEOUS BACTERIAL INFECTIONS • Folliculitis • Non bullous Impetigo/Bullous Impetigo • Furuncle/Carbuncle/Abscess • Cellulitis • Acute Paronychia • Dactylitis • Erysipelas • Impetiginization of dermatoses BACTERIAL INFECTION • Important to diagnose early • Almost always
  • Sexually Transmitted Infections

    Sexually Transmitted Infections

    MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH GUIDE TO SURVEILLANCE, REPORTING AND CONTROL Sexually Transmitted Infections June 2013 | Page 1 of 6 Section 1 ABOUT THE INFECTIONS Gonorrhea A. Etiologic Agent Neisseria gonorrhoeae are bacteria that appear as gram-negative diplococci on microscopic Gram-stained smear. B. Clinical Description Many infections occur without symptoms. Most males with urethral infection have symptoms of purulent or mucopurulent urethral discharge. Men may also have epididymitis due to N. gonorrhoeae . Most infections in women are asymptomatic. Symptoms in women can include abdominal pain, and mucopurulent or purulent cervical discharge. Women may also get urethritis. N. gonorrhoeae can cause pelvic inflammatory disease. Disseminated (bloodstream) infection can occur with rash, and joint and tendon inflammation. Infections of the throat and the rectum can also occur and are often asymptomatic. C. Vectors and Reservoirs Humans are the only known natural hosts and reservoirs of infection. D. Modes of Transmission Gonorrhea is transmitted through oral, vaginal, or anal sex. Gonorrhea can also be transmitted at birth through contact with an infected birth canal. E. Incubation Period The incubation period for gonorrhea is usually 2-7 days for symptomatic disease. F. Period of Communicability or Infectious Period All sexual contacts within 60 days of the onset of symptoms or diagnosis of gonorrhea should be evaluated and treated. Individuals with asymptomatic infection are infectious as long as they remain infected. G. Epidemiology Gonorrhea is the second most commonly reported notifiable disease in the U.S.; over 300,000 cases are reported annually. The number of reported cases underestimates true incidence. H. Treatment Ceftriaxone 250 mg IM x 1 dose PLUS EITHER Azithromycin 1 gram PO x 1 dose (preferred) OR Doxycycline 100 mg PO twice daily for 7 days is the recommended treatment in Massachusetts.
  • Table of Contents I. Introduction and Background:

    Table of Contents I. Introduction and Background:

    2013 State Reportable Conditions Assessment (SRCA) User Instructions Table of Contents I. Introduction and Background: ................................................................................................................................... 1 II. Tips for completing the SRCA ..................................................................................................................................... 2 III. Getting Started ........................................................................................................................................................... 2 IV. Managing Users and Assigning Sections for Data Entry ............................................................................................ 3 V. Entering Data for Reportable Conditions ................................................................................................................... 4 VI. 2012 Data Interpolation ............................................................................................................................................. 9 VII. Review and Submit Completed Data ....................................................................................................................... 10 VIII. APPENDIX 1: Alphabetical List of Conditions by Condition Category Grouping (*Nationally Notifiable Conditions [NNC]) ............................................................................................................................................................................... 11 IX. APPENDIX
  • Dermatology in the ER

    Dermatology in the ER

    DRUG ERUPTIONS and OTHER DISORDERS Lloyd J. Cleaver D.O. , F.A.O.C.D, F.A.A.D. Professor of Dermatology ATSU-Kirksville College of Osteopathic Medicine INTERNAL MEDICINE BOARD REVIEW COURSE I Disclosures No Relevant Financial Relationships DRUG ERUPTIONS Drug Reactions 3 things you need to know 1. Type of drug reaction 2. Statistics What drugs are most likely to cause that type of reaction? 3. Timing How long after the drug was started did the reaction begin? Clinical Pearls Drug eruptions are extremely common Tend to be generalized/symmetric Maculopapular/morbilliform are most common Best Intervention: Stop the Drug! Do not dose reduce Completely remove the exposure How to spot the culprit? Drug started within days to a week prior to rash Can be difficult and take time Tip: can generally exclude all drugs started after onset of rash Drug eruptions can continue for 1-2 weeks after stopping culprit drug LITT’s drug eruption database Drug Eruptions Skin is one of the most common targets for drug reactions Antibiotics and anticonvulsants are most common 1-5% of patients 2% of all drug eruptions are “serious” TEN, DRESS More common in adult females and boys < 3 y/o Not all drugs cause eruptions at same rate: Aminopenicillins: 1.2-8% of exposures TMP-SMX: 2.8-3.7% NSAIDs: 1 in 200 Lamotrigine: 10% Drug Eruptions Three basic rules 1. Stop any unnecessary medications 2. Ask about non-prescription medications Eye drops, suppositories, implants, injections, patches, vitamin and health supplements, friend’s medications
  • Dermatological Indications of Disease - Part II This Patient on Dialysis Is Showing: A

    Dermatological Indications of Disease - Part II This Patient on Dialysis Is Showing: A

    “Cutaneous Manifestations of Disease” ACOI - Las Vegas FR Darrow, DO, MACOI Burrell College of Osteopathic Medicine This 56 year old man has a history of headaches, jaw claudication and recent onset of blindness in his left eye. Sed rate is 110. He has: A. Ergot poisoning. B. Cholesterol emboli. C. Temporal arteritis. D. Scleroderma. E. Mucormycosis. Varicella associated. GCA complex = Cranial arteritis; Aortic arch syndrome; Fever/wasting syndrome (FUO); Polymyalgia rheumatica. This patient missed his vaccine due at age: A. 45 B. 50 C. 55 D. 60 E. 65 He must see a (an): A. neurologist. B. opthalmologist. C. cardiologist. D. gastroenterologist. E. surgeon. Medscape This 60 y/o male patient would most likely have which of the following as a pathogen? A. Pseudomonas B. Group B streptococcus* C. Listeria D. Pneumococcus E. Staphylococcus epidermidis This skin condition, erysipelas, may rarely lead to septicemia, thrombophlebitis, septic arthritis, osteomyelitis, and endocarditis. Involves the lymphatics with scarring and chronic lymphedema. *more likely pyogenes/beta hemolytic Streptococcus This patient is susceptible to: A. psoriasis. B. rheumatic fever. C. vasculitis. D. Celiac disease E. membranoproliferative glomerulonephritis. Also susceptible to PSGN and scarlet fever and reactive arthritis. Culture if MRSA suspected. This patient has antithyroid antibodies. This is: • A. alopecia areata. • B. psoriasis. • C. tinea. • D. lichen planus. • E. syphilis. Search for Hashimoto’s or Addison’s or other B8, Q2, Q3, DRB1, DR3, DR4, DR8 diseases. This patient who works in the electronics industry presents with paresthesias, abdominal pain, fingernail changes, and the below findings. He may well have poisoning from : A. lead. B.